Market Closed -
Australian S.E.
11:40:05 29/04/2024 am IST
|
5-day change
|
1st Jan Change
|
1.22
AUD
|
+2.09%
|
|
+1.24%
|
-25.38%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,879
|
1,899
|
2,772
|
2,089
|
1,811
|
885.8
|
-
|
-
|
Enterprise Value (EV)
1 |
2,558
|
2,565
|
2,977
|
2,614
|
2,258
|
2,374
|
2,305
|
2,232
|
P/E ratio
|
32.8
x
|
-27
x
|
66.1
x
|
7.06
x
|
-4.92
x
|
-1.51
x
|
30.1
x
|
17.8
x
|
Yield
|
2.38%
|
0.85%
|
2.86%
|
4.36%
|
-
|
-
|
1.76%
|
3.24%
|
Capitalization / Revenue
|
1.04
x
|
1.19
x
|
1.46
x
|
0.89
x
|
1.06
x
|
0.52
x
|
0.49
x
|
0.47
x
|
EV / Revenue
|
1.42
x
|
1.6
x
|
1.57
x
|
1.12
x
|
1.32
x
|
1.38
x
|
1.28
x
|
1.18
x
|
EV / EBITDA
|
10.8
x
|
16.3
x
|
5.79
x
|
3.39
x
|
6
x
|
6.69
x
|
5.76
x
|
5.14
x
|
EV / FCF
|
53.3
x
|
-
|
7.87
x
|
5.17
x
|
8.34
x
|
9.81
x
|
7.13
x
|
6.62
x
|
FCF Yield
|
1.88%
|
-
|
12.7%
|
19.3%
|
12%
|
10.2%
|
14%
|
15.1%
|
Price to Book
|
0.91
x
|
0.98
x
|
1.49
x
|
1.09
x
|
1.2
x
|
0.81
x
|
0.83
x
|
0.81
x
|
Nbr of stocks (in thousands)
|
6,22,322
|
6,22,742
|
5,98,674
|
5,69,207
|
5,69,529
|
7,26,100
|
-
|
-
|
Reference price
2 |
3.020
|
3.050
|
4.630
|
3.670
|
3.180
|
1.220
|
1.220
|
1.220
|
Announcement Date
|
15/08/19
|
20/08/20
|
29/08/21
|
29/08/22
|
29/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,804
|
1,600
|
1,901
|
2,338
|
1,707
|
1,715
|
1,800
|
1,892
|
EBITDA
1 |
236
|
157
|
513.8
|
770.8
|
376.2
|
355.1
|
400.4
|
434
|
EBIT
1 |
167.3
|
102.7
|
266.5
|
492.3
|
99
|
66.05
|
106.7
|
131.3
|
Operating Margin
|
9.27%
|
6.42%
|
14.02%
|
21.06%
|
5.8%
|
3.85%
|
5.93%
|
6.94%
|
Earnings before Tax (EBT)
1 |
83.2
|
46.4
|
167.8
|
416.9
|
-397.3
|
-325.4
|
40.43
|
63.2
|
Net income
1 |
55.9
|
-70.5
|
43.7
|
307.9
|
-367.8
|
-631.9
|
26.38
|
45.21
|
Net margin
|
3.1%
|
-4.41%
|
2.3%
|
13.17%
|
-21.55%
|
-36.84%
|
1.47%
|
2.39%
|
EPS
2 |
0.0920
|
-0.1130
|
0.0700
|
0.5200
|
-0.6460
|
-0.8099
|
0.0405
|
0.0684
|
Free Cash Flow
1 |
48
|
-
|
378.3
|
505.4
|
270.6
|
242.1
|
323.1
|
337
|
FCF margin
|
2.66%
|
-
|
19.9%
|
21.62%
|
15.85%
|
14.11%
|
17.95%
|
17.81%
|
FCF Conversion (EBITDA)
|
20.34%
|
-
|
73.63%
|
65.57%
|
71.93%
|
68.17%
|
80.7%
|
77.66%
|
FCF Conversion (Net income)
|
85.87%
|
-
|
865.68%
|
164.14%
|
-
|
-
|
1,224.83%
|
745.49%
|
Dividend per Share
2 |
0.0720
|
0.0260
|
0.1325
|
0.1600
|
-
|
-
|
0.0215
|
0.0396
|
Announcement Date
|
15/08/19
|
20/08/20
|
29/08/21
|
29/08/22
|
29/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
945.1
|
639.5
|
943.8
|
956.9
|
1,339
|
998.7
|
-
|
842.8
|
849
|
873.6
|
896
|
930.1
|
EBITDA
1 |
113
|
-
|
253.6
|
260.2
|
510.8
|
260
|
-
|
199.4
|
159.1
|
191.5
|
193.7
|
211.7
|
EBIT
1 |
75.7
|
-
|
136.6
|
129.9
|
376.1
|
116.2
|
-
|
59
|
15.7
|
49.7
|
45.4
|
57.2
|
Operating Margin
|
8.01%
|
-
|
14.47%
|
13.58%
|
28.09%
|
11.64%
|
-
|
7%
|
1.85%
|
5.69%
|
5.07%
|
6.15%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
66.3
|
-
|
62.8
|
-19.1
|
233.2
|
74.7
|
-
|
-339.1
|
-635.8
|
1.5
|
3.4
|
17.4
|
Net margin
|
7.02%
|
-
|
6.65%
|
-2%
|
17.42%
|
7.48%
|
-
|
-40.23%
|
-74.89%
|
0.17%
|
0.38%
|
1.87%
|
EPS
|
-
|
-
|
0.1010
|
-0.0310
|
0.3900
|
0.1300
|
-
|
-
|
-1.070
|
-
|
-
|
-
|
Dividend per Share
|
0.0260
|
-
|
0.0650
|
0.0675
|
0.1000
|
0.0600
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/02/20
|
20/08/20
|
23/02/21
|
29/08/21
|
22/02/22
|
29/08/22
|
26/02/23
|
29/08/23
|
26/02/24
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
678
|
666
|
205
|
525
|
447
|
1,489
|
1,419
|
1,346
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.874
x
|
4.242
x
|
0.3994
x
|
0.6809
x
|
1.188
x
|
4.192
x
|
3.544
x
|
3.101
x
|
Free Cash Flow
1 |
48
|
-
|
378
|
505
|
271
|
242
|
323
|
337
|
ROE (net income / shareholders' equity)
|
4.81%
|
2.78%
|
7.83%
|
16.3%
|
1.5%
|
-0.16%
|
2.84%
|
4.29%
|
ROA (Net income/ Total Assets)
|
2.88%
|
1.4%
|
3.55%
|
7.78%
|
0.66%
|
0.53%
|
1.61%
|
2.05%
|
Assets
1 |
1,942
|
-5,039
|
1,232
|
3,960
|
-55,742
|
-1,19,303
|
1,643
|
2,201
|
Book Value Per Share
2 |
3.300
|
3.100
|
3.100
|
3.380
|
2.640
|
1.510
|
1.470
|
1.500
|
Cash Flow per Share
2 |
0.2100
|
0.5400
|
0.6800
|
0.9900
|
0.5900
|
0.4400
|
0.4200
|
0.4300
|
Capex
1 |
79.6
|
122
|
48.4
|
81.4
|
62.7
|
59.8
|
60
|
60.7
|
Capex / Sales
|
4.41%
|
7.62%
|
2.55%
|
3.48%
|
3.67%
|
3.48%
|
3.33%
|
3.21%
|
Announcement Date
|
15/08/19
|
20/08/20
|
29/08/21
|
29/08/22
|
29/08/23
|
-
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
1.22
AUD Average target price
1.364
AUD Spread / Average Target +11.82% Consensus |
1st Jan change
|
Capi.
|
---|
| -25.38% | 566M | | -16.58% | 8.25B | | +41.01% | 3.58B | | -35.59% | 2.46B | | -7.88% | 2.46B | | -8.95% | 2.38B | | -6.98% | 1.81B | | -19.07% | 1.55B | | -38.35% | 1.21B | | +6.91% | 1.11B |
Medical & Diagnostic Laboratories
|